๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Synthesis of alkyl glycoside fatty acid esters: Effect of reaction parameters and the incorporation of n-3 polyunsaturated fatty acids

โœ Scribed by Casimir C. Akoh; Lydia N. Mutua


Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
484 KB
Volume
16
Category
Article
ISSN
0141-0229

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Phospholipid incorporation and metabolic
โœ B. Goustard-Langelier; J.M. Alessandri; G. Raguenez; G. Durand; Y. Courtois ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 105 KB ๐Ÿ‘ 1 views

The metabolic conversion of n-3 fatty acids was studied in the human Y79 retinoblastoma cell line. Cultured cells were exposed to increasing concentrations of either 18:3n-3, 22:5n-3, or 22:6n-3, and their phospholipid fatty acid composition was analyzed after 72 hr. Cells internalized the supplemen

Effect of polyunsaturated fatty acids an
โœ K. Madhavi Sekharam; Jawaharlal M. Patel; Edward R. Block ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 957 KB

## Abstract Vitamin E, a dietary antioxidant, is presumed to be incorporated into the lipid bilayer of biological membranes to an extent proportional to the amount of polyunsaturated fatty acids or phospholipids in the membrane. In the present study we evaluated the distribution of incorporated pol

Differential effects of n-6 and n-3 poly
โœ Ulrich Danesch; Peter C. Weber; Alois Sellmayer ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 869 KB

Dietary n-3 polyunsaturated fatty acids (PUFAs) have been found to reduce accelerated cell growth. To study the underlying molecular mechanisms, we evaluated the effects of the n-3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) compared with the n-6 PUFA arachidonic acid (AA) on ce

How good is the evidence for a favourabl
โœ John Stanley ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 411 KB

## Abstract The evidence for beneficial effects of very long chain (VLC) nโ€3 polyunsaturated fatty acids (PUFA) on cardiovascular disease (CVD) is strong because it is based on the results of adequately powered intervention trials with disease endpoints. This contrasts with the evidence for a detri